Depression and platelet activation in outpatients with stable coronary heart disease: Findings from the Heart and Soul Study

Psychiatry Research

Volumn 175, Issue 3, 2010, Pages 200-204

  Gehi, Anil ^a   Musselman, Dominique ^b   Otte, Christian ^c   Bruce Royster, Erica ^b   Ali, Sadia ^d   Whooley, Mary A ^d,e  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coronary heart disease; Depression; Mechanisms; Platelet activation

Indexed keywords

11 OXOTHROMBOXANE B2; ACETYLSALICYLIC ACID; BETA THROMBOGLOBULIN; PSYCHOTROPIC AGENT; THROMBOCYTE FACTOR 4;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MORBIDITY; MORTALITY; OUTPATIENT; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

AGED; BETA-THROMBOGLOBULIN; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PLATELET ACTIVATION; PLATELET FACTOR 4; QUESTIONNAIRES; RETROSPECTIVE STUDIES; T-BOX DOMAIN PROTEINS;

EID: 73449148992     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.01.010     Document Type: Article

References (47)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), APA, Washington, DC
2. Bingefors K., Isacson D., Knorring L.V., Smedby B., and Wicknertz K. Antidepressant-treated patients in ambulatory care. Mortality during a nine-year period after first treatment. British Journal of Psychiatry 169 (1996) 647-654
3. Blouin A.G., Perez E.L., and Blouin J.H. Computerized administration of the Diagnostic Interview Schedule. Psychiatry Research 23 (1988) 335-344
4. Carney R.M., Blumenthal J.A., Stein P.K., Watkins L., Catellier D., Berkman L.F., Czajkowski S.M., O'Connor C., Stone P.H., and Freedland K.E. Depression, heart rate variability, and acute myocardial infarction. Circulation 104 (2001) 2024-2028
5. Carney R.M., Freedland K.E., Miller G.E., and Jaffe A.S. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. Journal of Psychosomatic Research 53 (2002) 897-902
6. Chakhtoura E.Y., Shamoon F.E., Haft J.I., Obiedzinski G.R., Cohen A.J., and Watson R.M. Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings. American Journal of Cardiology 86 (2000) 835-839
7. Douketis J.D., Berger P.B., Dunn A.S., et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008) 299S-339S
8. Files J.C., Malpass T.W., Yee E.K., Ritchie J.L., and Harker L.A. Studies of human plate alpha-granule release in vivo. Blood 58 (1981) 607-618
9. Gavaghan T.P., Hickie J.B., Krilis S.A., Baron D.W., Gebski V., Low J., and Chesterman C.N. Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin. Journal of the American College of Cardiology 15 (1990) 1250-1258
10. Gurney D., Lip G.Y., and Blann A.D. A reliable plasma marker of platelet activation: does it exist?. American Journal of Hematology 70 (2002) 139-144
11. Kuijpers P.M., Hamulyak K., Strik J.J., Wellens H.J., and Honig A. Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression. Psychiatry Research 109 (2002) 207-210
12. Laghrissi-Thode F., Wagner W.R., Pollock B.G., Johnson P.C., and Finkel M.S. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biological Psychiatry 42 (1997) 290-295
13. Lederbogen F., Gilles M., Maras A., et al. Increased platelet aggregability in major depression?. Psychiatry Research 102 (2001) 255-261
14. Levine S.P., Towell B.L., Suarez A.M., Knieriem L.K., Harris M.M., and George J.N. Platelet activation and secretion associated with emotional stress. Circulation 71 (1985) 1129-1134
15. Levitan R.D., Blouin A.G., Navarro J.R., and Hill J. Validity of the computerized DIS for diagnosing psychiatric inpatients. Canadian Journal of Psychiatry 36 (1991) 728-731
16. Malkoff S.B., Muldoon M.F., Zeigler Z.R., and Manuck S.B. Blood platelet responsivity to acute mental stress. Canadian Journal of Psychiatry 55 (1993) 477-482
17. Marasini B., Biondi M.L., Barbesti S., Zatta G., and Agostoni A. Cigarette smoking and platelet function. Thrombosis Research 44 (1986) 85-94
18. Mehta J., and Mehta P. Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease. Circulation 66 (1982) 1294-1299
19. Musselman D.L., Tomer A., Manatunga A.K., Knight B.T., Porter M.R., Kasey S., Marzec U., Harker L.A., and Nemeroff C.B. Exaggerated platelet reactivity in major depression. American Journal of Psychiatry 153 (1996) 1313-1317
20. Musselman D.L., Marzec U.M., Manatunga A., Penna S., Reemsnyder A., Knight B.T., Baron A., Hanson S.R., and Nemeroff C.B. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Archives of General Psychiatry 57 (2000) 875-882
21. Nemeroff C.B., and Musselman D.L. Are platelets the link between depression and ischemic heart disease?. American Heart Journal 140 (2000) 57-62
22. Otte C., Marmar C.R., Pipkin S.S., Moos R., Browner W.S., and Whooley M.A. Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: the Heart and Soul Study. Biological Psychiatry 56 (2004) 241-247
23. Otte C., Neylan T.C., Pipkin S.S., Browner W.S., and Whooley M.A. Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study. American Journal of Psychiatry 162 (2005) 2139-2145
24. Patel P.B., Pfau S.E., Cleman M.W., Brennan J.J., Howes C., Remetz M., Cabin H.S., Setaro J.F., and Rinder H.M. Comparison of coronary artery specific leukocyte-platelet conjugate formation in unstable versus stable angina pectoris. American Journal of Cardiology 93 (2004) 410-413
25. Perneby C., Granstrom E., Beck O., Fitzgerald D., Harhen B., and Hjemdahl P. Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. Thrombosis Research 96 (1999) 427-436
26. Robins L.N., Helzer J.E., Croughan J., and Ratcliff K.S. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Archives of General Psychiatry 38 (1981) 381-389
27. Ruo B., Rumsfeld J.S., Hlatky M.A., Liu H., Browner W.S., and Whooley M.A. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 290 (2003) 215-221
28. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Journal of the American Society of Echo Cardiography 2 (1989) 358-367
29. Schins A., Honig A., Crijns H., Baur L., and Hamulyak K. Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link?. Psychosomatic Medicine 65 (2003) 729-737
30. Schins A., Hamulyak K., Scharpé S., Lousberg R., Van Melle J., Crijns H., and Honig A. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sciences 76 (2004) 637-650
31. Schmitz G., Rothe G., Ruf A., Barlage S., Tschöpe D., Clemetson K.J., Goodall A.H., Michelson A.D., Nurden A.T., and Shankey T.V. European working group on clinical cell analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thrombosis and Haemostosis 79 (1998) 885-896
32. Serebruany V.L., Glassman A.H., Malinin A.I., Atar D., Sane D.C., Oshrine B.R., Ferguson J.J., and O'Connor C.M. Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. European Journal of Heart Failure 5 (2003) 517-521
33. Serebruany V.L., Glassman A.H., Malinin A.I., Nemeroff C.B., Musselman D.L., van Zyl L.T., Finkel M.S., Krishnan K.R., Gaffney M., Harrison W., Califf R.M., O'Connor C.M., and Sertraline AntiDepressant Heart Attack Randomized Trial Study Group. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 108 (2003) 939-944
34. Serebruany V.L., Glassman A.H., Malinin A.I., Sane D.C., Finkel M.S., Krishnan R.R., Atar D., Lekht V., and O'Connor C.M. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagulation and Fibrinolysis 14 (2003) 563-567
35. Serebruany V.L., Gurbel P.A., and O'Connor C.M. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacological Research 43 (2001) 453-462
36. Serebruany V.L., O'Connor C.M., and Gurbel P.A. Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. American Journal of Cardiology 87 (2001) 1398-1400
37. Smith K.A., Fairburn C.G., and Cowen P.J. Relapse of depression after rapid depletion of tryptophan. Lancet 349 (1997) 915-919
38. Spitzer R.L., Kroenke K., and Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282 (1999) 1737-1744
39. Stuart M.J., Murphy S., and Oski F.A. A simple nonradioisotope technic for the determination of platelet life-span. New England Journal of Medicine 292 (1975) 1310-1313
40. Tsiara S., Elisaf M., Jagroop I.A., and Mikhailidis D.P. Platelets as predictors of vascular risk: is there a practical index of platelet activity?. Clinical and Applied Thrombosis/Hemostasis 9 (2003) 177-190
41. van Hulsteijn H., Bertina R., and Briet E. A one-year follow-up study of plasma fibrinopeptide A and beta-thromboglobulin after deep vein thrombosis and pulmonary embolism. Thrombosis Research 27 (1982) 225-229
42. von Kanel R. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?. Acta Psychiatrica Scandinavica 110 (2004) 163-177
43. Whooley M.A. Depression and cardiovascular disease: healing the broken-hearted. JAMA 295 (2006) 2874-2881
44. Whooley M.A., de Jonge P., Vittinghoff E., Otte C., Moos R., Carney R.M., Ali S., Dowray S., Na B., Feldman M.D., Schiller N.B., and Browner W.S. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300 (2008) 2379-2388
45. Whyte E.M., Pollock B.G., Wagner W.R., Mulsant B.H., Ferrell R.E., Mazumdar S., and Reynolds C.F.III. Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression. American Journal of Psychiatry 158 (2001) 2074-2076
46. Willerson J.T., Golino P., Eidt J., Campbell W.B., and Buja L.M. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation 80 (1989) 198-205
47. Ziegelstein R.C. Depression in patients recovering from a myocardial infarction. JAMA 286 (2001) 1621-1627